Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs

A. Ambrosini, F. Pierelli, Jean Schoenen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Mild subclinical impairment of neuromuscular transmission can be detected with single-fibre electromyography (SFEMG) in subgroups of patients suffering from migraine and could be due to dysfunctioning Ca2+-channels on motor axons controlling stimulation-induced acetylcholine release. Acetazolamide, which is thought to ameliorate ion channel function, was shown effective in familial hemiplegic migraine and episodic ataxia type 2, both of which are associated with mutations of the neuronal Ca2+-channel gene CACNA1A, as well as in aura status. We treated therefore in an open pilot study five non-hemiplegic migraineurs showing mild SFEMG abnormalities with acetazolamide for several weeks. This was followed by a normalization of SFEMG recordings in all patients and by clinical improvement in four. These results support the assumption that the subclinical impairment of neuromuscular transmission found in certain migraineurs might be due to dysfunctioning Ca2+-channels.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalCephalalgia
Volume23
Issue number2
DOIs
Publication statusPublished - Mar 2003

Fingerprint

Acetazolamide
Electromyography
Migraine with Aura
Migraine Disorders
Ion Channels
Acetylcholine
Axons
Epilepsy
Mutation
Genes

Keywords

  • Acetazolamide
  • Migraine
  • Neuromuscular transmission
  • P/Q-type Ca-channels
  • Single-fibre EMG

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. / Ambrosini, A.; Pierelli, F.; Schoenen, Jean.

In: Cephalalgia, Vol. 23, No. 2, 03.2003, p. 75-78.

Research output: Contribution to journalArticle

@article{26fdb10fa04c4a08a73e0790655145c8,
title = "Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs",
abstract = "Mild subclinical impairment of neuromuscular transmission can be detected with single-fibre electromyography (SFEMG) in subgroups of patients suffering from migraine and could be due to dysfunctioning Ca2+-channels on motor axons controlling stimulation-induced acetylcholine release. Acetazolamide, which is thought to ameliorate ion channel function, was shown effective in familial hemiplegic migraine and episodic ataxia type 2, both of which are associated with mutations of the neuronal Ca2+-channel gene CACNA1A, as well as in aura status. We treated therefore in an open pilot study five non-hemiplegic migraineurs showing mild SFEMG abnormalities with acetazolamide for several weeks. This was followed by a normalization of SFEMG recordings in all patients and by clinical improvement in four. These results support the assumption that the subclinical impairment of neuromuscular transmission found in certain migraineurs might be due to dysfunctioning Ca2+-channels.",
keywords = "Acetazolamide, Migraine, Neuromuscular transmission, P/Q-type Ca-channels, Single-fibre EMG",
author = "A. Ambrosini and F. Pierelli and Jean Schoenen",
year = "2003",
month = "3",
doi = "10.1046/j.1468-2982.2003.00409.x",
language = "English",
volume = "23",
pages = "75--78",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs

AU - Ambrosini, A.

AU - Pierelli, F.

AU - Schoenen, Jean

PY - 2003/3

Y1 - 2003/3

N2 - Mild subclinical impairment of neuromuscular transmission can be detected with single-fibre electromyography (SFEMG) in subgroups of patients suffering from migraine and could be due to dysfunctioning Ca2+-channels on motor axons controlling stimulation-induced acetylcholine release. Acetazolamide, which is thought to ameliorate ion channel function, was shown effective in familial hemiplegic migraine and episodic ataxia type 2, both of which are associated with mutations of the neuronal Ca2+-channel gene CACNA1A, as well as in aura status. We treated therefore in an open pilot study five non-hemiplegic migraineurs showing mild SFEMG abnormalities with acetazolamide for several weeks. This was followed by a normalization of SFEMG recordings in all patients and by clinical improvement in four. These results support the assumption that the subclinical impairment of neuromuscular transmission found in certain migraineurs might be due to dysfunctioning Ca2+-channels.

AB - Mild subclinical impairment of neuromuscular transmission can be detected with single-fibre electromyography (SFEMG) in subgroups of patients suffering from migraine and could be due to dysfunctioning Ca2+-channels on motor axons controlling stimulation-induced acetylcholine release. Acetazolamide, which is thought to ameliorate ion channel function, was shown effective in familial hemiplegic migraine and episodic ataxia type 2, both of which are associated with mutations of the neuronal Ca2+-channel gene CACNA1A, as well as in aura status. We treated therefore in an open pilot study five non-hemiplegic migraineurs showing mild SFEMG abnormalities with acetazolamide for several weeks. This was followed by a normalization of SFEMG recordings in all patients and by clinical improvement in four. These results support the assumption that the subclinical impairment of neuromuscular transmission found in certain migraineurs might be due to dysfunctioning Ca2+-channels.

KW - Acetazolamide

KW - Migraine

KW - Neuromuscular transmission

KW - P/Q-type Ca-channels

KW - Single-fibre EMG

UR - http://www.scopus.com/inward/record.url?scp=0037343526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037343526&partnerID=8YFLogxK

U2 - 10.1046/j.1468-2982.2003.00409.x

DO - 10.1046/j.1468-2982.2003.00409.x

M3 - Article

VL - 23

SP - 75

EP - 78

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 2

ER -